Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
3SBio ( (HK:1530) ) has provided an update.
3SBio has declared a conditional special dividend to shareholders, to be implemented via a distribution in specie of all the shares it holds in its subsidiary Mandi Inc. The distribution will allocate Mandi shares proportionally to qualifying 3SBio shareholders based on their holdings on a record date to be set later.
The payout is subject to shareholder approval at an extraordinary general meeting and to the successful completion of Mandi’s proposed spin-off, global offering and separate listing on the Hong Kong Stock Exchange. The board will determine the final distribution mechanics once the mandate is obtained, and the company has cautioned investors that the spin-off and related distribution may not proceed if regulatory, market or board approvals are not secured.
The most recent analyst rating on (HK:1530) stock is a Hold with a HK$25.00 price target. To see the full list of analyst forecasts on 3SBio stock, see the HK:1530 Stock Forecast page.
More about 3SBio
3SBio Inc., incorporated in the Cayman Islands and listed in Hong Kong, operates in the biopharmaceutical sector. The company focuses on developing and commercializing pharmaceutical products, and it actively manages its portfolio through capital market transactions, including spin-offs and separate listings of subsidiaries to unlock value for shareholders.
YTD Price Performance: -0.83%
Average Trading Volume: 23,046,124
Technical Sentiment Signal: Buy
Current Market Cap: HK$60.86B
See more insights into 1530 stock on TipRanks’ Stock Analysis page.